Wang, H Y; Jiang, X; Gozes, I et al. (1999) Vasoactive intestinal peptide inhibits cytokine production in T lymphocytes through cAMP-dependent and cAMP-independent mechanisms. Regul Pept 84:55-67
|
Xin, Z; Sun, L; Ganea, D (1997) Vasoactive intestinal peptide stimulates p59fyn kinase activity in murine thymocytes. Peptides 18:1151-9
|
Xin, Z; Jiang, X; Wang, H Y et al. (1997) Effect of vasoactive intestinal peptide (VIP) on cytokine production and expression of VIP receptors in thymocyte subsets. Regul Pept 72:41-54
|
McCormack, R J; Hart, R P; Ganea, D (1996) Expression of NK-1 receptor mRNA in murine T lymphocytes. Neuroimmunomodulation 3:35-46
|
Wang, H Y; Xin, Z; Tang, H et al. (1996) Vasoactive intestinal peptide inhibits IL-4 production in murine T cells by a post-transcriptional mechanism. J Immunol 156:3243-53
|
Johnson, M C; McCormack, R J; Delgado, M et al. (1996) Murine T-lymphocytes express vasoactive intestinal peptide receptor 1 (VIP-R1) mRNA. J Neuroimmunol 68:109-19
|
Martinez, C; Delgado, M; Gomariz, R P et al. (1996) Vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide-38 inhibit IL-10 production in murine T lymphocytes. J Immunol 156:4128-36
|
Delgado, M; Martinez, C; Johnson, M C et al. (1996) Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes. J Neuroimmunol 68:27-38
|
Xin, Z; Tang, H; Ganea, D (1994) Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production in murine thymocytes activated via the TCR/CD3 complex. J Neuroimmunol 54:59-68
|
Sun, L; Ganea, D (1993) Vasoactive intestinal peptide inhibits interleukin (IL)-2 and IL-4 production through different molecular mechanisms in T cells activated via the T cell receptor/CD3 complex. J Neuroimmunol 48:59-69
|